Four serum amyloid A protein (SAA) genes and two SAA gene products, SAA1 and SAA2, were identified in BALB/c mice. Using analytical isoelectric focusing we have identified a quantitatively significant new member of the SAA family and designated it 'SAA5'. This protein has characteristics never before described for any SAA molecule. In the highly conserved region between amino acids 33 and 44, identical in all SAAs from all species examined, SAA5 had four amino acid substitutions. In addition, the induction of SAA5 by lipopolysaccharide had different kinetics from that of the other mouse SAAs. Our data suggest that the mouse SAA gene family is more complex in composition and regulation than previously surmised.
INTRODUCTION
Serum amyloid A protein (SAA) is one of the major acutephase reactants_synthesized by the liver upon cytokine stimulation [1] . Its concentration can increase 1000-fold by increased transcription and mRNA stabilization [2] . It is an apolipoprotein of the high-density-lipoprotein (HDL) complex. During the acute-phase response, SAA can constitute as much as 80 % of the total protein of HDL particles [3, 4] . Given the phylogenetic conservation of SAA and the enormous surge in synthesis during inflammation, it is likely that the function of SAA is important and beneficial [5] . SAA is the precursor of amyloid A protein (AA), which aggregates into the fibrillar deposits of systemic amyloidosis [6] . Several isoforms of SAA have been identified in man [7, 8] , hamster [9, 10] and mouse [3] . In the mouse, two distinct isotypes, SAA1 and SAA2, are present in nearly equal amounts on HDL [3] . Only mouse SAA2 has been reported to give rise to amyloid A (AA) of amyloid deposits [10] . Four SAA genes have been characterized in BALB/c mice [12] [13] [14] [15] . There is a pseudogene (SAA4) lacking exons 1 and 2 and 25 bp in exon 3 , resulting in an in-frame stop codon [13] [14] [15] . Two genes encode the SAA1 and SAA2 isotypes. Another gene encoding SAA3 is transcribed in the liver co-ordinately with the SAA1 and SAA2 genes, but a corresponding protein has not been found [2, 11] . On the basis of computer modelling, which predicted a pI of 10.35 for the protein product of the SAA3 gene (corrected value of 9.2) [16] , we used expanded basic electrofocusing gradients as well as a variety of anti-SAA antibodies to search for this protein in BALB/c mice. Although a SAA3-gene protein product was not identified, at this basic pH range we did discover a distinct new member of the murine SAA family as an acute-phase apolipoprotein of BALB/c HDL. We designated this protein 'SAA5 the product of a new gene: the SAA5 gene.
MATERIALS AND METHODS
Female BALB/c mice, 2 
Preparation of HDL
To isolate HDL from plasma, the density was adjusted to 1.09 g/ml with solid KBr and the plasma was centrifuged for 5.3 h at 242000 g in a VTi8O rotor (Beckman Instruments, Palo Alto, CA, U.S.A.) at 10 'C. The infranatants containing HDL were collected, the density re-adjusted to 1.21 g/ml with solid KBr and re-centrifuged for 9.4 h at 242000 g in a VTi8O rotor at 10 'C. The pellicles containing HDL were extensively dialysed against 0.15 M-NaCI/0.01 % (w/v) EDTA, pH 7.4 [4, 8] .
Electrofocusing
In order to expand the basic pH range of electrofocusing gels, ultrathin acrylamide gels were cast containing 20 % (v/v) ampholines pH 3-10, 40% (v/v) ampholines pH 4-6.5 and 40 % (v/v) ampholines pH 7-9 [8, 16] (Pharmacia LKB Biotechnology, Piscataway, NJ, U.S.A.). Aliquots (200,g) of mouse HDL, or 20 ,1 of mouse plasma collected during the time course, were freeze-dried and delipidated with 0.5 ml of chloroform/methanol (2:1, v/v) [17] . The delipidated proteins were resuspended in 1 % (w/v) sodium decyl sulphate (Eastman Kodak Co., Rochester, NY, U.S A.)/7 M-urea/5 % (v/v) 2-mercaptoethanol and electrofocused as described in [8, 16] .
Immunochemical analysis
Samples on electrofocused gels were pressure-blotted on to 0.2 ,um-pore-size nitrocellulose membranes (Schleicher and Schuell, Keene, NH, U.S.A.) overnight at room temperature [8] . Reverse-phase h.p.l.c. of peptides Peptides generated by enzymic cleavage were desalted and separated by reverse-phase h.p.l.c. on a 4.6 mm x 250 mm Vydac (Hesperia, CA, U.S.A.) C18 column (TP silica). Elution was with a linear gradient of acetonitrile in 0.06 % trifluoroacetic acid at a flow rate of 1 ml/min. Absorbance was monitored at 214 nm. U.v.-absorbing peaks were collected and subjected to amino acid sequence analysis. A Hewlett-Packard 1050 h.p.l.c. system, consisting of a quartenary pump, autosampler, variable-wavelength detector and a model 3396 integrator, was used for all chromatography.
Amino acid sequencing
All protein-sequence analysis was performed at the Macromolecular Structure Analysis Facility at the University of Kentucky on an Applied Biosystems (Foster City, CA, U.S.A.) model-477A protein sequencer with on-line phenylthiohydantoin identification. For N-terminal sequencing, 3 mg of acute-phase BALB/c HDL was electrofocused as described above and SAA5 electroblotted on to PVDF membrane. Direct sequencing of the protein blotted on to PVDF was performed by using a precycled Polybrene-coated glass-fibre disc and sequencer cycles modified for use with PVDF [22,231.
Quantification of SAA isoforms
Coomassie Blue-stained SAA isoforms were excised from electrofocused gels and the dye extracted with 25 % (v/v) pyridine. The dye was quantified by measuring the absorbance at 605 nm and comparing it with that of reference proteins of known protein concentration [24] .
SDS/PAGE
For molecular-mass analysis, protein bands were excised from Coomassie Blue-stained electrofocused gels, boiled in SDS sample buffer and resolved by electrophoresis in a 5-20 %-acrylamide/SDS gel with a 3 % acrylamide stacking gel [18] . In order to optimize protein staining, several bands of a particular pI were pooled.
Glycosylation analysis
Acute-phase HDL from BALB/c mice (1 mg) was electrofocused in 200 ,g aliquots. The Coomassie Blue-stained SAAs bands were excised, pooled and electroblotted on to 0.22 gm-pore-size nitrocellulose membrane (Schleicher and Schuell) as described above. The glycosylation state of SAA6 was investigated by using a glycan detection kit (Boehringer Mannheim) according to the manufacturer's instructions.
RESULTS

Analytical electrofocusing and immunochemical analysis of BALB/c HDL
The comparative isoelectric focusing of normal and acutephase HDL from BALB/c mice showed the presence of a prominent acute-phase reactant at pl 8.1 (Fig. la) (Fig. lb) . The SAA-like character of this protein was suggested by positive staining with a rabbit anti-(human SAA) (amino acid residues 95-104) antibody (Fig. lb) . An antibody raised against a synthetic peptide modelled on the first 12 amino acids of the putative mouse SAA3 failed to react with any BALB/c apolipoprotein (results not shown).
LPS induction of mouse SAA: time course
The relative presence of SAA1, SAA2 and SAA5 in blood collected from BALB/c mice at various times after LPS injection is shown in Fig. 2 Immunochemical staining of SAA isotypes in electrofocused plasma samples BALB/c mice were killed at the times indicated after LPS injection. In (a), SAA5 was identified with a rabbit anti-(human SAA) (residues 95-104) antibody. In (b), SAA1 and SAA2 were detected with a rabbit anti-(mouse AA) antibody.
Molecular-mass analysis SAA5 had a molecular mass of 14 kDa as determined by SDS/PAGE of excised electrofocused bands (Fig. 3) . It was marginally larger than SAA1 and SAA2 (Fig. 3) . The increased size was not the result of glycosylation (results not shown).
Quantification of SAA5
SAA5 was quantified in HDL prepared from the plasma of BALB/c mice killed 20 or 30 h after LPS injection. At 20 h, SAAI and SAA2 each constituted approx. 40 % and SAA5 5 % of total HDL SAA. Minor SAA isoforms made up the remaining 15 % of HDL SAA. At 30 h SAA1 and SAA2 each constituted only approx. 35 % and the SAA5 15 % of the total HDL SAA, the remaining 15 % being contributed by minor SAA isoforms.
Amino acid sequence N-Terminal sequencing, as well as sequencing of peptides generated by the digestion of SAA5 with trypsin, Endoproteinase Lys-C and Endoproteinase Asp-N, provided the amino acid sequence of SAA5 shown in Fig. 4 .
The reverse-phase h.p.l.c. separation of peptides generated by trypsin digestion of SAA5 yielded the profile in Fig. 5(a) , peaks T1-T7 providing the sequences shown in Fig. 4 . Peak T6 represented an incomplete digest, and in peak T7 the first amino acid, glutamic acid, was not assigned.
The Endoproteinase Lys-C digestion -of SAA5 provided only two prominent peaks after h.p.l.c. (Fig. Sb) . These peaks provided sequences toward the C-terminal part of the molecule (Fig. 4) .
Peptides The amino acid sequence was obtained from N-terminal sequencing ('NH2') and peptides generated by fragmentation with trypsin -('T'), Endoproteinase Lys-C (' L') and Endoproteinase Asp-N ('A').
Numbering is from the N-terminal end of the protein.
Vol. 280. 10 20 Mouse SAA, [25] . One of these SAA-like molecules, which has a molecular mass of 14 kDa and a pl of 8.0, shows 44% N-terminal similarity to our SAA-like protein. Sack & Talbot have described another member of the human SAA gene family, gSAA p, which codes for a protein of 104 amino acids [26] . This SAA protein, which has yet to be identified, differs from the described human SAA proteins [16] in several usually conserved sequences. However, the sequence of its first 25 amino acids is virtually identical with that of the SAA-like protein described by Brinckerhoffet al. [25] . Furthermore, Ramadori et al. have raised antibodies against 12.5 kDa and 14.5 kDa proteins produced by mouse liver and peritoneal macrophages [27] . These antibodies did not bind to the 'classical' mouse SAAs, though various antisera against mouse AA bound to the 12.5 kDa and 14.5 kDa proteins [27] . Our findings provide definitive proof for the existence of another gene product (SAA5) in BALB/c mice.
The pl of SAA5 (8.1) is considerably more basic than that of SAA1 (6.45) and SAA2 (6.3) . Basic proteins such as SAA5 would not readily be detected in electrofocusing gradients used to date for the analysis of mouse SAA isoforms. Use of such gradients, as well as the slower kinetics of SAA5 induction, may explain why this molecule had thus far escaped identification.
The pI of the SAA3 protein is predicted to be 10.35, but when this value is corrected, a pl of 9.2 is obtained [16] . In electrofocused gels that had not been focused to completion no migrating proteins more basic than SAA5 had been observed.
Our findings therefore indicate that the SAA3 protein is not an apolipoprotein of BALB/c HDL.
Microsequencing strategies were employed to obtain amino acid sequence data for subsequent definitive probe design and genetic analysis. These strategies were successful in providing 56 N-terminal and 35 C-terminal residues. The number of intervening residues is uncertain in that the SAA5 protein had a molecular mass which was marginally higher than that of SAA1 or SAA2. A conceivable explanation for the small increase in size might be the presence of an insert of several extra amino acids, as is the case in the cow, horse, cat and dog [28] [29] [30] . In these animals, eight or nine amino acids were found to be inserted in the region of amino acids 69-70, a section of SAA5 that we have not sequenced.
SAA of various species differ most in exon 2 and 4, respectively coding for the N-and C-termini. Exon 3 has diverged less than exon 4 and, in particular, encodes a highly conserved region between amino acids 33-44 [13] . It is notable that SAA5 differed in four of the 13 amino acids of this exon 3 region, which could imply a different function for this protein.
The first 56 amino acids of SAA5 had 61, 57 and 57% similarity with SAA1, SAA2 and SAA3 respectively. Amino acids 69-103 (part of exon 4) of SAA5 had 63 % similarity with SAA3 and only 51% with SAA1 and SAA2. It is notable that 74% of the amino acids conserved among SAA1, SAA2 and SAA3 were also conserved in SAA5. Overall, on the basis of available sequence data, SAA5 had 56% similarity to the SAA1/SAA2 subfamily and 59 % similarity to SAA3.
The mouse SAA-gene family has been most extensively studied in BALB/c mice and was said to consist of at least three genes and a pseudogene residing within a 79 kb region of chromosome 7 [13, 15] . It was suggested that an ancestral SAA gene gave rise to the SAA3 gene and a pre-SAA1,24 gene and that the latter subsequently duplicated into the SAA4 gene (pseudogene) and a pre-SAA1,2 gene. Gene conversion of the latter resulted in the present SAA1 and SAA2 genes [13] [14] [15] . The most likely explanation for the existence of SAA 5 that it has evolved, like the SAA3 gene, through a distinct ancestral gene-duplication event. This is suggested by its sequence similarities with the SAA JSAA2 and SAA3 subfamilies, which characterize it as a new subfamily equally related to the previous two.
The fact that SAA5 induction temporally differed from the other mouse SAAs is of interest in that it has not previously been shown in any other SAA from all species examined. Whether the induction of SAAs is mediated by different cytokines or whether there is differential control at the transcriptional or translational level, needs to be explored. Alternatively SAA5 might have different associative kinetics with HDL. Our data could expand the potential of the mouse model to study cytokine-induced and differential acute-phase gene expression.
The discovery of a new SAA molecule in BALB/c mice implies that the mouse SAA-gene family is more complex than previously surmised. We view it as important that both molecular-biological and analytical-protein-chemical approaches be employed to elucidate the diversity of the SAA-gene family. 
